Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/177061
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGianaroli, Luca-
dc.contributor.authorAta, Baris-
dc.contributor.authorLundin, Kersti-
dc.contributor.authorRautakallio-Hokkanen, Satu-
dc.contributor.authorTapanainen, Juha S.-
dc.contributor.authorVermeulen, Nathalie-
dc.contributor.authorVeiga, Anna-
dc.contributor.authorMocanu, Edgar-
dc.contributor.authorESHRE COVID-19 Working Group-
dc.date.accessioned2021-05-06T10:10:33Z-
dc.date.available2021-05-06T10:10:33Z-
dc.date.issued2020-11-30-
dc.identifier.urihttp://hdl.handle.net/2445/177061-
dc.description.abstractThe coronavirus disease 2019 (COVID-19) pandemic created a significant impact on medically assisted reproduction (MAR) services. ESHRE decided to mobilize resources in order to collect, analyse, monitor, prepare and disseminate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) knowledge specifically related to ART and early pregnancy. This article presents the impact of the SARS-CoV-2 pandemic focusing on reproductive healthcare. It details the rationale behind the guidance prepared to support MAR services in organizing and managing the re-start of treatments or in case of any future wave of COVID-19 disease. The guidance includes information on patient selection and informed consent, staff and patient triage and testing, adaptation of ART services, treatment planning and code of conduct. The initiatives detailed in this article are not necessarily COVID-specific and such action plans could be applied effectively to manage similar emergency situations in different areas of medicine, in the future.-
dc.format.extent8 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherOxford University Press-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1093/humrep/deaa285-
dc.relation.ispartofHuman Reproduction, 2020, vol. 36, num. 2, p. 275-282-
dc.relation.urihttps://doi.org/10.1093/humrep/deaa285-
dc.rightscc by-nc (c) Gianaroli et al., 2021-
dc.rights.urihttp://creativecommons.org/licenses/by-nc/3.0/es/*
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))-
dc.subject.classificationCOVID-19-
dc.subject.classificationSARS-CoV-2-
dc.subject.classificationReproducció humana assistida-
dc.subject.otherCOVID-19-
dc.subject.otherSARS-CoV-2-
dc.subject.otherHuman reproductive technology-
dc.titleThe calm after the storm: re-starting ART treatments safely in the wake of the COVID-19 pandemic-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.date.updated2021-05-06T07:27:42Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid33017461-
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
deaa285.pdf367.48 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons